StonvexLoading…
StonvexStonvexStonvexCore line items from SRRK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $33.19M | $18.82M | $15.40M |
Operating Income | $-384.64M | $-134.37M | $-129.92M | $-86.88M |
Net Income | $-377.94M | $-134.50M | $-131.80M | $-86.48M |
EPS (Diluted) | $-3.29 | $-2.26 | $-3.59 | $-2.81 |
Total Assets | $404.27M | $358.17M | $304.44M | $388.31M |
Total Liabilities | $158.78M | $97.93M | $132.37M | $127.53M |
Cash & Equivalents | $323.53M | $103.28M | $212.84M | $160.36M |
Free Cash Flow OCF − CapEx | $-300.64M | $-133.76M | $-132.04M | $-64.36M |
Shares Outstanding | 108.46M | 51.67M | 35.21M | 34.15M |